Shortness of Breath: An Uncommon Side-Effect of Cyproterone Acetate in the Treatment of Androgenetic Alopecia

    Rica Mallari, Rodney Sinclair
    Studysummary This case study reports a 66-year-old woman developing shortness of breath while taking 50 mg/day of cyproterone acetate for androgenetic alopecia, a complication not previously documented in women with this condition.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 1

    1. Female Androgenetic Alopecia: An Update Australasian Journal of Dermatology · 1995

    Related research 2

    1. Shortness of Breath: An Uncommon Side-Effect of Cyproterone Acetate in the Treatment of Androgenetic Alopecia International Journal of Dermatology · 2002
    2. Treatment of Hirsutism, Acne, and Alopecia with Cyproterone Acetate Dermatology · 1980